Sign In
Manage PermissionsManage Permissions

HEALTH and Cosmetic Products Found Adulterated

HEALTH AND COSMETIC PRODUCTS FOUND ADULTERATED

The Ministry of Health would like to alert members of the public to Two (2) types of health product and Two (2) types of cosmetic product which have been tested by the Laboratory of Pharmacy Section, Department of Scientific Services, Ministry of Health and found to be adulterated with undeclared, potent western medicine.

           

The affected health products are listed as below:

 

No.Name of productManufacturerAdulterated with
1.Ubat Resdung Mujarab KapsulNot StatedChlorpheniramine, Dexamethasone, Betamethasone
2.Mujarab Resdong Plus KapsulMRP Marketing, Sabah, MalaysiaChlorpheniramine, Dexamethasone, Betamethasone, Prednisolone

 

Whilst the affected cosmetic products areas listed below:

 

No.Name of productManufacturerAdulterated with
1.White Horse Gluta by JL Fara 1 Tumeric Night CreamNot statedMercury
2.White Horse Gluta by JL Fara 2 Seaweed Night CreamNot statedMercury

 

The adulterant found in these products can cause adverse effects that are potentially hazardous to the people using them.

 

Dizziness, lowering of blood pressure, irregular hearbeat, confusion, depression and convulsions are among the adverse effects that could occur from the unsupervised consumption of Chlorpheniramine.

 

Unsupervised long-term consumption of potent corticosteroids such as Dexamethasone, Betamethasone and Prednisolone can cause increase blood glucose levels leading to diabetes, high blood pressure, cataracts, muscular and bone disorders, and an increased risk of infections. Long term use of corticosteroids can also lead to Cushing's syndrome which is characterized by a round face or 'moon face', and upper body obesity with thin limbs.


Consumers who have taken high doses of steroids over a prolonged period of time may suffer from withdrawal symptoms which include fatigue, muscle and joint pain, fever, low blood sugar, low blood pressure and dehydration.

 

Mercury is a potent ingredient that is prohibited in cosmetic products as stipulated in the Medicines (Cosmetic Products) Regulations 2007.

 

Mercury is prohibited in cosmetic products due to its hazardous effects on human health. It is readily absorbed through the skin on topical application and tends to accumulate in the body. Exposure to mercury can cause skin rashes, memory loss and muscle weakness while high exposures may result in damage to the brain and kidneys. It is also extremely toxic to unborn children.

 

The Ministry of Health has not issued any approval for the importation for the sale of these products and/or Cosmetic Notification Acknowledgement Letter for the sale of the rest of affected products. Following these findings, the products are not allowed to be imported and sold in Brunei Darussalam.

 

Members of the public who have purchased or used these products are advised to stop using them immediately. They should also consult a medical practitioner if they feel unwell or experience any undesirable reactions as a result of using them.

 

Members of the public involved in the retail of these products (including online retail such as through Facebook, etc.) are hereby reminded that it is an offence under the Poisons Act 1956 to sell any product containing any substance controlled under the said Act and the penalty for such an offence upon conviction, is a fine of $8,000 or six months' imprisonment. Furthermore, if a person commits an Act that amounts to such a degree of negligence so as to endanger or be likely to endanger human life, then such person shall be guilty of an offence which carries a penalty of a fine of $16,000 and 12 months' imprisonment. The public are also reminded that it is an offence under the Medicines (Cosmetic Products) Regulations, 2007 to import and market cosmetic products in the local market without a Cosmetic Product Notification Acknowledgement Letter issued by the Authority, where the penalty for contravening these regulations upon conviction, is a fine not exceeding $5,000, imprisonment for a term not exceeding two years or both.

 

The Ministry of Health would also like to call upon the public for their cooperation to report to the Compliance and Licensing Section if any of these products are still found on the market in this country.

 

For further information and communication, the public may contact the Compliance and Licensing Section at 2393298 extension 208; send an e-mail to pharmacy.enforcement@moh.gov.bn; go directly to 1st Floor, Compliance and Licensing Section, Department of Pharmaceutical Services' Building, Kg. Madaras, Mukim Gadong A; or call the Talian Darussalam 123.

- E N D -

Reference     : KK/PR/3

Date               : 30 October 2019 / 2 Rabiulawal 1441H


Attachments